» Articles » PMID: 36889679

Assessment of Cognitive Functioning Using the Mini Mental State Examination in Men with Alcohol and Crack Cocaine Use Disorder

Abstract

Introduction: Consumption of substances has been associated with cognitive impairment. The Mini Mental State Examination (MMSE) is an easy-to-apply screening tool used to assess cognitive functions.

Objectives: To evaluate the cognitive performance of individuals with alcohol (AUD) and/or crack cocaine use disorder (CUD) and polysubstance use using the MMSE and to investigate the impact of substance use profile and the moderation effect of educational level on MMSE performance.

Methods: Cross-sectional study with 508 adult male inpatients diagnosed with substance use disorders (245 with AUD, 85 with CUD, and 178 with polysubstance use). Cognitive performance was assessed using the MMSE scale (total and composite scores).

Results: Individuals with AUD had worse total MMSE scores and scored worse for all three MMSE components compared to individuals with polysubstance use (p < 0.001, oral/written language comprehension, p < 0.001, attention/memory, and p = 0.007, motor functions). MMSE scores were positively correlated with educational level (p < 0.017), but were not associated with age, recent drug use, or years of drug use. Educational level moderated the impact of substance use on MMSE performance, especially total score and composite language comprehension score. Individuals with a low educational level (≤ 8 years) had worse performance than those with a high educational level (≥ 9 years), mainly in individuals with AUD (p < 0.001).

Discussion: Individuals with a low educational level and alcohol use are more prone to present cognitive impairment than crack cocaine users, especially involving language aspects. Better-preserved cognitive function could impact treatment adherence and might guide the decision of therapeutic strategies.

Citing Articles

Impact of alcohol use disorder on cognition in correlation with aging: a community-based retrospective cohort study.

Essa H, Ali H, Min P, Ali D, Lowe V, Petersen R Alcohol Alcohol. 2024; 60(1).

PMID: 39602567 PMC: 11601986. DOI: 10.1093/alcalc/agae080.

References
1.
Copersino M, Fals-Stewart W, Fitzmaurice G, Schretlen D, Sokoloff J, Weiss R . Rapid cognitive screening of patients with substance use disorders. Exp Clin Psychopharmacol. 2009; 17(5):337-44. PMC: 3144764. DOI: 10.1037/a0017260. View

2.
Volkow N, Michaelides M, Baler R . The Neuroscience of Drug Reward and Addiction. Physiol Rev. 2019; 99(4):2115-2140. PMC: 6890985. DOI: 10.1152/physrev.00014.2018. View

3.
Czermainski F, Willhelm A, Santos A, Pacheco Pachado M, de Almeida R . Assessment of inhibitory control in crack and/or cocaine users: a systematic review. Trends Psychiatry Psychother. 2017; 39(3):216-225. DOI: 10.1590/2237-6089-2016-0043. View

4.
Fernandez-Serrano M, Perez-Garcia M, Rio-Valle J, Verdejo-Garcia A . Neuropsychological consequences of alcohol and drug abuse on different components of executive functions. J Psychopharmacol. 2009; 24(9):1317-32. DOI: 10.1177/0269881109349841. View

5.
Kessler F, Cacciola J, Alterman A, Faller S, Souza-Formigoni M, Cruz M . Psychometric properties of the sixth version of the Addiction Severity Index (ASI-6) in Brazil. Braz J Psychiatry. 2012; 34(1):24-33. DOI: 10.1590/s1516-44462012000100006. View